Medical News

RSS

Dyax' Phase 3 hereditary angioedema clinical program affirms reliability of its novel PROs

Dyax Corp. (NASDAQ:DYAX) today announced a study published evaluating the Company’s novel Patient Reported Outcome Measures (PROs) used to assess hereditary angioedema (HAE) attacks affirmed the PROs as valuable instruments in capturing HAE symptom severity and impact of treatment.

11 Sep 2009

Results from a preclinical study of Variation's influenza vaccine to be presented at ICAAC meeting

Variation Biotechnologies, Inc. (VBI), an emerging leader in the discovery and development of novel vaccines to fight infectious diseases, today announced that it plans to present positive results from a preclinical study of the company’s proprietary influenza vaccine at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), being held at the Moscone Convention Center in San Francisco, California.

11 Sep 2009

Brigham & Women's Hospital to implement Patient Safety's Safety-Sponge System

Patient Safety Technologies (OTC Bulletin Board: PSTX) announced that it has signed a contract with Partners HealthCare and will be implementing its Safety-Sponge(TM) System at Brigham & Women's Hospital.

11 Sep 2009

FHA and SFHHA announce an agreement with the ECRI Institute for patient safety data collection

The Florida Hospital Association (FHA) and the South Florida Hospital & Healthcare Association (SFHHA) today announce an agreement with the ECRI Institute Patient Safety Organization (PSO) to support the Patient Safety Organization of Florida (PSOFlorida) with patient safety data collection and analysis. PSOFlorida, a component organization of the FHA and the SFHHA, was established to focus on improving the quality of care that hospitals in Florida provide to the state's residents and visitors.

11 Sep 2009

Nova Biomedical's subsidiary Sanvita CBGM to acquire assets of CCS Medical's subsidiary, Sanvita Inc

Nova Biomedical Corporation, a leading developer of whole blood analyzers, and CCS Medical, Inc. a leading direct-to-consumer provider of medical supplies, today announced that they have reached a definitive agreement under which Nova Biomedical's independent, wholly owned subsidiary, Sanvita CBGM, LLC, will acquire certain assets of Sanvita, Inc., a wholly-owned subsidiary of CCS Medical. Sanvita, Inc. is currently the exclusive distributor of Nova's "NovaMax" consumer blood glucose product line in the United States.

11 Sep 2009

Elderberry extract prevents H1N1 infection in vitro

A recent research study has given new scientific evidence to the long-held empirical belief that elderberries possess antiviral activities. The research involved a specific, reproducible elderberry extract developed by HerbalScience Group LLC, and succeeded in identifying key chemical components of the extract that inhibited in vitro infection and were shown to bind directly to Human Influenza A (H1N1) virus particles. The binding blocked the ability of the viruses to enter host cells, and thereby effectively preventing H1N1 infection in vitro.

11 Sep 2009

Wisconsin researchers identify the genetic region responsible for cardiovascular collapse during anesthesia

Researchers at The Medical College of Wisconsin in Milwaukee have identified the genetic region in rats responsible for cardiovascular collapse during anesthesia. While it is well known that people have different cardiovascular sensitivity to anesthesia causing some to collapse even when low doses are administered, the mechanism responsible for this susceptibility is not clear.

11 Sep 2009

One-fifth of Americans follow health news very closely: Pew Research Center

Approximately one-fifth of Americans follow health news very closely, according to the Pew Research Center. To identify how the demand for health stories is met, University of Missouri researchers surveyed national health journalists about their development of story ideas and use of expert sources and public relations materials.

11 Sep 2009

U.S. Secretary Kathleen Sebelius to participate in a vaccination exercise on the anniversary of 9/11

On the anniversary of 9/11, U.S. Secretary of Health and Human Services Kathleen Sebelius and Assistant Secretary for Health Howard Koh will honor the members of the Medical Reserve Corps and participate in a vaccination exercise in Alexandria, Va., on Friday, September 11, 2009.

11 Sep 2009

USPTO allows Isis an additional patent for single-stranded RNAi technology

Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office (USPTO) has allowed an Isis patent application that further expands the scope of the "Crooke" patent estate. The newly allowed patent broadly covers methods of cleaving a target RNA via a double-stranded ribonuclease mechanism, including the RNAi mechanism, with chemically modified, single-stranded RNA-containing drugs.

11 Sep 2009

Pergamum to develop Karolinska dermatology and wound healing companies

Pergamum AB has announced its formation; Pergamum will commercialize the Karolinska Development dermatology and wound healing interests, and create a broad-based therapeutic company in its focus areas.

11 Sep 2009

New venture capital program will help life science companies in western Pennsylvania: Governor Rendell

Early-stage life science companies in western Pennsylvania will be able to expand and create quality jobs with the help of a state investment in venture capital, Governor Edward G. Rendell said today.

11 Sep 2009

Solta Medical launches new Thermage CPT and Fraxel re:store Dual systems

Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.

11 Sep 2009

RWJF selects Regions Hospital to take part in its effort to improve cardiac care delivered in hospitals

MN Community Measurement today announced that Regions Hospital has been selected by the Robert Wood Johnson Foundation (RWJF) to participate in a new effort to improve the quality -- and equality -- of cardiac care delivered in hospitals. The Aligning Forces for Quality: Equity Quality Improvement Collaborative (Equity QI Collaborative) will identify and test ways for hospitals to improve the quality and efficiency of their cardiac care, while also identifying and reducing any racial and ethnic disparities.

11 Sep 2009

First Edition: September 11, 2009

Today's headlines are full of second-day stories about the policies and politics involved in President Obama's Wednesday night address to Congress.

11 Sep 2009

VHGI to distribute Secure Document Courier and Storage technology

VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.

11 Sep 2009

USPTO recognizes RZN Nutraceuticals' HerbaZorb as a patentable delivery system

RZN Nutraceuticals, Inc.,(www.rznnutra.com) a leading developer of proven effective herbal products which have been clinically tested on sufferers of severe arthritis and migraines has announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for the firm's absorption and delivery system process methodology patent application, a technology RZN has named HerbaZorb(TM).

11 Sep 2009

Bioidentical hormone therapy is safe and effective for menopausal women

Life Extension(R), the company that long ago sounded the alarm on the dangers of synthetic hormone replacement therapy for menopausal women, has published still more proof that bioidentical hormones offer a far safer treatment option.

11 Sep 2009

Delcath Systems to continue Phase III clinical trial

Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the Data and Safety Monitoring Board ("DSMB") reviewed clinical data on 77 patients enrolled in its pivotal Phase III clinical trial and unanimously recommended that the trial continue to enroll patients with the goal of reaching the 92 patients required to complete the study.

11 Sep 2009

Pluristem begins enrollment following FDA approval for clinical trials of its PLX-PAD stem cell product

Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company’s leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).

11 Sep 2009

Medical News

Dyax' Phase 3 hereditary angioedema clinical program affirms reliability of its novel PROs

Results from a preclinical study of Variation's influenza vaccine to be presented at ICAAC meeting

Brigham & Women's Hospital to implement Patient Safety's Safety-Sponge System

FHA and SFHHA announce an agreement with the ECRI Institute for patient safety data collection

Nova Biomedical's subsidiary Sanvita CBGM to acquire assets of CCS Medical's subsidiary, Sanvita Inc

Elderberry extract prevents H1N1 infection in vitro

Wisconsin researchers identify the genetic region responsible for cardiovascular collapse during anesthesia

One-fifth of Americans follow health news very closely: Pew Research Center

U.S. Secretary Kathleen Sebelius to participate in a vaccination exercise on the anniversary of 9/11

USPTO allows Isis an additional patent for single-stranded RNAi technology

Pergamum to develop Karolinska dermatology and wound healing companies

New venture capital program will help life science companies in western Pennsylvania: Governor Rendell

Solta Medical launches new Thermage CPT and Fraxel re:store Dual systems

RWJF selects Regions Hospital to take part in its effort to improve cardiac care delivered in hospitals

First Edition: September 11, 2009

VHGI to distribute Secure Document Courier and Storage technology

USPTO recognizes RZN Nutraceuticals' HerbaZorb as a patentable delivery system

Bioidentical hormone therapy is safe and effective for menopausal women

Delcath Systems to continue Phase III clinical trial

Pluristem begins enrollment following FDA approval for clinical trials of its PLX-PAD stem cell product

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News